Key result
Palliative anticoagulation with low-molecular weight heparin calcium allowed a 55-year-old female with advanced hepatocellular carcinoma and massive pulmonary embolism to survive for nearly 2 months.
Case Report (n=1)
This case highlights the rapid and fatal progression of hepatocellular carcinoma complicated by right atrial tumor thrombi and massive pulmonary embolism despite anticoagulation therapy.
May extend brief survival with anticoagulation in advanced HCC with PE; leaves open optimal management strategies.
The aim of the present study was to report the case of a 55-year-old female patient with a sizeable (7.1×6.2 cm) hepatocellular carcinoma (HCC), who succumbed to massive pulmonary artery embolism. The main symptoms included sudden thoracodynia, dyspnea and transient coma. The initial diagnosis was HCC according to the typical abdominal ultrasound and triple-phase abdominal computed tomography (CT) findings, chronic hepatitis B infection and elevated α-fetoprotein levels (1,036 µg/l; normal, 0-20 µg/l). Two days following admission, the patient developed recurrent chest pain and shortness of breath. The electrocardiogram and myocardial enzyme levels were normal, but the D-dimer level was elevated to 7,210 µg/l (normal, 0-550 µg/l). Magnetic resonance angiography and a contrast-enhanced chest CT confirmed that the inferior vena cava and right atrium were invaded by tumor thrombi; the bilateral pulmonary embolism was also suspected to be formed by tumor thrombi. The final diagnosis was HCC with inferior vena caval and right atrial tumor thrombi, as well as massive pulmonary embolism. Anticoagulation therapy with low-molecular weight heparin calcium was administered; however, the patient succumbed to pulmonary embolism in <2 months.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2016) conducted a case report in Hepatocellular carcinoma with pulmonary artery embolism (n=1). Low-molecular weight heparin calcium was evaluated on Survival. Palliative anticoagulation with low-molecular weight heparin calcium allowed a 55-year-old female with advanced hepatocellular carcinoma and massive pulmonary embolism to survive for nearly 2 months.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: